Diffuse-type tenosynovial giant cell tumour of the temporo-mandibular joint: an indication for alloplastic joint replacement


Diffuse-type tenosynovial giant cell tumour of the temporo-mandibular joint: an indication for alloplastic joint replacement


An-Sofie Vandeput1, MD; Michel Bila1, MD; Titiaan Dormaar1, MD; Anne-Marie Delsupehe2, MD; Constantinus Politis1, MD, PhD

1Department of Oral and Maxillofacial Surgery, University Hospital Leuven, Leuven, Belgium; 2Department of Pathology, University Hospital Leuven, Leuven, Belgium


A 25-year old female patient was referred to our department with a mass at the level of the right temporomandibular joint (TMJ). The patient experienced symptoms of paroxysmal pain of the TMJ and weight loss. Magnetic resonance imaging (MRI) revealed a tumour in the right masticatory space extending into the right TMJ, with invasion of the temporal bone. Surgical resection of the mass and total TMJ replacement surgery with a custom-made pros-thesis were performed. Final histological diagnosis of the resected specimen showed a dif-fuse-type tenosynovial giant cell tumour (D-TGCT). The multidisciplinary team’s decision was to give adjuvant radiotherapy; however, the patient declined further treatment. At 6 months follow-up, the patient had an excellent recovery with no signs of tumour recurrence on MRI. This is the first described case of D-TGCT treated with total TMJ replacement sur-gery using a custom-made alloplastic device.


Keywords: tenosynovial giant cell tumour; temporomandibular joint; alloplastic joint re-placement; prosthesis


Free Full-text PDF


How to cite this article:

An-Sofie Vandeput; Michel Bila; Titiaan Dormaar; Anne-Marie Delsupehe; Constantinus Politis. Diffuse-type tenosynovial giant cell tumour of the temporo-mandibular joint: an indication for alloplastic joint replacement. International Journal of Case Reports, 2020 4:188. DOI: 10.28933/ijcr-2020-11-1206


References:

1. Lucas DR. Tenosynovial giant cell tumor: case report and review. Arch Pathol Lab Med 2012;136;901-6.
2. Fletcher JA, Henkle C, Atkins L, et al. Trisomy 5 and trisomy 7 are nonrandom aberrations in pigmented villonodular synovitis: confirmation of trisomy 7 in uncultured cells. Genes Chromosomes Cancer 1992;4;264-6.
3. Nilsson M, Hoglund M, Panagopoulos I, et al. Molecular cytogenetic mapping of recurrent chromosomal breakpoints in tenosynovial giant cell tumors. Virchows Arch 2002;441;475-80.
4. Verspoor FGM, Mastboom MJL, Weijs WLJ, et al. Treatments of tenosynovial giant cell tumours of the temperomandibular joint: a report of three cases and a review of literature. Int J Oral Maxillofac Surg 2018;47;1288-94.
5. Mastboom MJL, Verspoor FGM, Verschoor AJ, et al. Higher incidence rates than previously known in tenosynovial giant cell tumors. Acta Orthop 2017;88;688-94.
6. Wang JG, Liu J, He B, et al. Diffuse Tenosynovial Giant Cell Tumor Around the Temporomandibular Joint: An Entity With Special Radiologic and Pathologic Features. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 2019;77;1022.e1-.e39.
7. Hamza A, Gidley PW, Learned KO, et al. Uncommon tumors of temporomandibular joint: An institutional experience and review. Head & neck 2020.
8. Bridge JA, Hogendoorn P, Fletcher CDM, et al. WHO Classification of Tumours of Soft Tissue and Bone. 4th ed. Lyon: International Agency for Research on Cancer; 2013. 1 online resource (471 pages) p.
9. Mastboom MJL, Palmerini E, Verspoor FGM, et al. Surgical outcomes of patients with diffuse-type tenosynovial giant-cell tumours: an international, retrospective, cohort study. The Lancet Oncology 2019;20;877-86.